405887-36-7 Usage
Uses
Used in Organic Synthesis:
1N-Boc 3-(4'-nitrophenoxy) pyrrolidine is used as a building block for the synthesis of various organic compounds. Its unique structure and reactivity allow for the creation of a wide range of molecules with diverse properties and applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1N-Boc 3-(4'-nitrophenoxy) pyrrolidine serves as a key intermediate in the development of new drugs and biologically active molecules. Its presence in the molecular structure can contribute to the desired pharmacological properties of the final drug candidates.
Used in Pharmaceutical Industry:
1N-Boc 3-(4'-nitrophenoxy) pyrrolidine is used as a precursor in the synthesis of various pharmaceuticals. Its versatile reactivity and protective Boc group enable the synthesis of complex drug molecules with specific therapeutic targets and improved pharmacokinetic profiles.
Used in Agrochemical Industry:
1N-Boc 3-(4'-nitrophenoxy) pyrrolidine is also utilized in the agrochemical industry as a precursor for the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure can contribute to the development of more effective and environmentally friendly agrochemicals.
Used in Functional Materials:
1N-Boc 3-(4'-nitrophenoxy) pyrrolidine can be employed in the development of functional materials with specific properties, such as sensors, catalysts, or advanced materials for various applications. Its reactivity and structural features make it a promising candidate for the design of novel materials with improved performance.
Check Digit Verification of cas no
The CAS Registry Mumber 405887-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,8,8 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 405887-36:
(8*4)+(7*0)+(6*5)+(5*8)+(4*8)+(3*7)+(2*3)+(1*6)=167
167 % 10 = 7
So 405887-36-7 is a valid CAS Registry Number.
405887-36-7Relevant academic research and scientific papers
BISARYLUREA DERIVATIVES
-
Page/Page column 204-205, (2010/02/13)
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
DIAMINOTHIAZOLES
-
Page/Page column 25, (2010/02/05)
The present invention is directed to novel diaminothiazoles of formula These compounds inhibit cyclin-dependent kinase 4 (Cdk4) and are selective against Cdk2 and Cdk1. These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors. This invention is also directed to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment 6r control of breast, lung and colon and prostate tumors.
